Patents by Inventor Jianhao LI

Jianhao LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250123259
    Abstract: System and method for analyzing gas composition content of transformer oil are provided. The analysis system includes a ten-way switching valve, a sample loop, a first chromatographic column, a second chromatographic column, a thermal conductivity cell detector, a four-way switching valve, a third chromatographic column, and a carbon composition detection device. A first composition fitted peak and a second composition fitted peak are sequentially separated from a transformer oil sample by the first chromatographic column, the first composition fitted peak is a fitted peak of hydrogen, oxygen, and nitrogen; and the second composition fitted peak is a fitted peak of carbon monoxide, methane, carbon dioxide, and a C2 hydrocarbon compositions.
    Type: Application
    Filed: September 9, 2024
    Publication date: April 17, 2025
    Inventors: Chaoqing LI, Fude WANG, Jianhao LI
  • Patent number: 12276737
    Abstract: Disclosed is a suppression method for a multipath signal of an image mode based on correlation peaks of a satellite baseband signal, including the steps of: constructing a real-world direct-multipath two-dimensional color image mode data set; and building a multipath suppression model of a deep learning network based on a long-short term memory (LSTM) and a self-attention mechanism module, and training the model. In the present disclosure, a satellite signal can be quickly captured without losing the sensitivity of the captured signal, and a Beidou satellite baseband signal can be captured from a signal recorded in the real world, which enables the model to learn complex signal patterns, improving the accuracy and robustness of multipath signal suppression in urban complex scenes.
    Type: Grant
    Filed: December 17, 2024
    Date of Patent: April 15, 2025
    Assignee: Guangdong University of Technology
    Inventors: Shengli Xie, Zhenni Li, Kungan Zeng, Rong Yuan, Kan Xie, Jianhao Tang, Mingwei Wang, Victor Fedorovich Kuzin
  • Publication number: 20250118890
    Abstract: a transmission device and the fabricating method therefor, a quantum device integration component and a quantum computer, and belongs to the field of quantum information. The transmission device includes: a substrate; a micro-strip line layer formed on the substrate; a dielectric layer formed on the micro-strip line layer; and a ground layer and a port pad formed on the dielectric layer, wherein the ground layer is electrically connected to a ground plate of the micro-strip line layer, and the port pad is electrically connected to a conductor strip of the micro-strip line layer. The transmission device can be fabricated based on the existing integrated circuit fabricating process. In this transmission device, the micro-strip line layer can have a multi-layer stacking arrangement, so that high-density wiring on the substrate with a limited area can be achieved to adapt to the packaging needs of large-scale quantum chips.
    Type: Application
    Filed: January 18, 2024
    Publication date: April 10, 2025
    Inventors: Hui ZHANG, Hui YANG, Ye LI, Jianhao JIA
  • Patent number: 12258317
    Abstract: An isoquinolinone compound acts as an inhibitor of semicarbazide-sensitive oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1), and the use thereof, and further relates to a pharmaceutical composition containing the compound. The compound or the pharmaceutical composition can be used to prepare a drug for preventing, treating or ameliorating inflammation and/or inflammation-related diseases, diabetes and/or diabetes-related diseases in patients, and especially can be used to prepare a drug for preventing, treating or ameliorating non-alcoholic fatty liver diseases in patients.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: March 25, 2025
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng Gu, Jianhao Li, Weihua Wang, Haoxiong Qin, Xinshan Deng
  • Publication number: 20250024801
    Abstract: The present disclosure relates to a method for activating a crop seed by high-voltage electric field cold plasma (HVCP), and use thereof, belonging to the technical field of crop planting. The present disclosure provides a method for activating a crop seed by HVCP, including the following steps: (1) mixing a crop seed with water and immersing the crop seed in water for 4 h to 24 h to obtain an immersed crop seed; and (2) conducting discharge activation on the immersed crop seed at a voltage of 80 kV to 130 kV to obtain an activated crop seed. In the present disclosure, the method can improve heat-resistant and disease-resistant properties of crops, and provide a scientific basis for subsequent acquisition of excellent seeds.
    Type: Application
    Filed: December 5, 2022
    Publication date: January 23, 2025
    Inventors: Xilin HOU, Dong XIAO, Ying HE, Ying LI, Jianhao ZHANG, Jinglin WAN
  • Patent number: 12097686
    Abstract: The present application discloses a high-barrier polyolefin composite film, including, from the outside to the inside, an outer PE film, a water-barrier layer, a high-barrier PVA coating layer, an adhesive layer, and an inner PE film, wherein the inner PE film comprises the following raw materials in percentage by weight: 10-20% of HDPE, 30-50% of MDPE, 20-26% of LLDPE, 10-20% of LDPE, 8-12% of a water- and oxygen-barrier masterbatch, and 1-3% of an auxiliary agent; the water- and oxygen-barrier masterbatch includes the following raw materials in parts by weight: 10-20 parts of polycarbonate, 0.1-0.3 parts of a compatibilizer, 10-20 parts of an ethylene-vinyl acetate copolymer (EVA), 1-2 parts of single-layer graphene, and 1-2 parts of polyhedral oligomeric silsesquioxane.
    Type: Grant
    Filed: March 25, 2024
    Date of Patent: September 24, 2024
    Assignees: DAWN ZHOUSHI (QINGDAO) MULTI-LAYER PACKAGING MATERIAL CO., LTD., QINGDAO BIOBORN PACKAGING CO., LTD.
    Inventors: Shuangli Li, Suocheng Yang, Rui Zhou, Shun Gao, Tao Wang, Jianhao Li
  • Publication number: 20240025875
    Abstract: A compound serving as a thyroid hormone ? receptor agonist and uses of the compound, also provided is a pharmaceutical composition comprising the compound. The compound or the pharmaceutical composition is applicable in preparing a medicament for preventing, treating, or alleviating thyroid hormone ? receptor agonist-modulated diseases, and specifically applicable in preparing a medicament for treating nonalcoholic fatty liver disease.
    Type: Application
    Filed: September 16, 2021
    Publication date: January 25, 2024
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Jianhao LI, Jianchao DENG, Yongxiang LI, Haoxiong QIN, Daoqian CHEN, Xiaomin ZHENG, Jianghong YU, Huantian ZHAO
  • Patent number: 11795082
    Abstract: Disclosed is a split continuous operation micro-grid dynamic membrane bioreactor. The split continuous operation micro-grid dynamic membrane bioreactor comprises a biological treatment unit and a drum dynamic membrane filtration unit, wherein the biological treatment unit comprises a microbiological treatment tank, and a water inlet pipe is arranged on the microbiological treatment tank; the drum dynamic membrane filtration unit comprises a filter tank, and a drum micro-grid dynamic membrane mechanism is arranged in the filter tank; the drum micro-grid dynamic membrane mechanism comprises a filter drum, a backwashing device is arranged above the filter drum, and a sludge collecting tank is arranged in the filter drum; a water outlet is formed in the bottom of the filter tank; a mixed liquid pipe is arranged between the microbiological treatment tank and the filter drum; and a sludge discharge header pipe is arranged on the sludge collecting tank.
    Type: Grant
    Filed: August 9, 2021
    Date of Patent: October 24, 2023
    Inventors: Li Gu, Xiaofeng Xu, Jianhao Li, Wen Li, Meng Gao, Hua Xiang, Qiang He
  • Publication number: 20220411400
    Abstract: A chemical compound as a thyroid hormone Beta receptor agonist and a use thereof, further including a pharmaceutical composition containing the chemical compound. The chemical compound or pharmaceutical composition can be used in the preparation of drugs for preventing, treating or mitigation of diseases mediated by agonistic thyroid hormone ? receptor, particularly for the preparation of drugs for treating non-alcoholic fatty liver diseases.
    Type: Application
    Filed: September 23, 2020
    Publication date: December 29, 2022
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Jianhao LI, Xinshan DENG, Zheng LI, Daoqian CHEN, Jianchao DENG, Aizhen LV, Jianyu LIU
  • Publication number: 20220315536
    Abstract: An isoquinolinone compound acts as an inhibitor of semicarbazide-sensitive oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1), and the use thereof, and further relates to a pharmaceutical composition containing the compound. The compound or the pharmaceutical composition can be used to prepare a drug for preventing, treating or ameliorating inflammation and/or inflammation-related diseases, diabetes and/or diabetes-related diseases in patients, and especially can be used to prepare a drug for preventing, treating or ameliorating non-alcoholic fatty liver diseases in patients.
    Type: Application
    Filed: May 20, 2020
    Publication date: October 6, 2022
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Jianhao LI, Weihua WANG, Haoxiong QIN, Xinshan DENG
  • Patent number: 11396495
    Abstract: An amine compound serving as a semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, and an application thereof in medicines that can be used for treating inflammation and/or inflammation related diseases, diabetes and/or a disease related diabetes, psychiatric disorder, ischemic disease, vascular disease, fibrosis, or tissue transplant rejection.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: July 26, 2022
    Assignee: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng Gu, Jianhao Li, Zheng Li, Weihua Wang, Haoxiong Qin, Xuli Wang, Jianyu Liu, Yingjun Zhang
  • Publication number: 20220055930
    Abstract: Disclosed is a split type continuous operation micro-grid dynamic membrane bioreactor. The split type continuous operation micro-grid dynamic membrane bioreactor comprises a biological treatment unit and a drum type dynamic membrane filtration unit, wherein the biological treatment unit comprises a microbiological treatment tank, and a water inlet pipe is arranged on the microbiological treatment tank; the drum type dynamic membrane filtration unit comprises a filter tank, and a drum micro-grid dynamic membrane mechanism is arranged in the filter tank; the drum micro-grid dynamic membrane mechanism comprises a filter drum, a backwashing device is arranged above the filter drum, and a sludge collecting bank is arranged in the filter drum; a water outlet is formed in the bottom of the filter tank; a mixed liquid pipe is arranged between the microbiological treatment tank and the filter drum; and a sludge discharge header pipe is arranged on the sludge collecting tank.
    Type: Application
    Filed: August 9, 2021
    Publication date: February 24, 2022
    Inventors: Li GU, Xiaofeng XU, Jianhao LI, Wen LI, Meng GAO, Hua XIANG, Qiang HE
  • Publication number: 20200377461
    Abstract: An amine compound serving as a semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, and an application thereof in medicines that can be used for treating inflammation and/or inflammation related diseases, diabetes and/or a disease related diabetes, psychiatric disorder, ischemic disease, vascular disease, fibrosis, or tissue transplant rejection.
    Type: Application
    Filed: December 28, 2018
    Publication date: December 3, 2020
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Zheng GU, Jianhao LI, Zheng LI, Weihua WANG, Haoxiong QIN, Xuli WANG, Jianyu LIU, Yingjun ZHANG